US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Arcutis Biotherapeutics Inc.

23.63

-0.4700-1.95%

Post-market: 23.22-0.4145-1.75%19:56 EDT

Volume:1.09M

Turnover:25.84M

Market Cap:2.93B

PE:-186.27

High:24.08

Open:23.40

Low:23.20

Close:24.10

52wk High:31.77

52wk Low:11.86

Shares:124.03M

Float Shares:88.24M

Volume Ratio:0.82

T/O Rate:1.24%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.1269

EPS(LYR):-0.1269

ROE:-9.30%

ROA:-1.95%

PB:15.47

PE(LYR):-186.27

Loading ...

Overview Company News Filings

Arcutis Biotherapeutics Inc - FDA Sets Pdufa Target Date for June 29, 2026

THOMSON REUTERS

FDA Accepts Supplemental New Drug Application for Arcutis’ Zoryve® (Roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5

THOMSON REUTERS

Executive VP & Chief Commercial Officer Of Arcutis Biotherapeutics Sold 40% Of Their Shares

Simply Wall St.

Arcutis Biotherapeutics Completes Enrollment for Phase 2 Study of Investigational Treatment for Atopic Dermatitis

MT Newswires Live

BRIEF-Arcutis Canada Says Health Canada Approves ZORYVE Foam 0.3% For Scalp, Body Psoriasis For Adults & Adolescents 12 & Older

Refile-Arcutis Canada: Health Canada Approves Zoryve Foam 0.3% for Scalp, Body Psoriasis for Adults & Adolescents 12 & Older (Removes Extra Words)

THOMSON REUTERS

Arcutis Biotherapeutics Inc - Topline Results Expected in Q1 2026

THOMSON REUTERS

Arcutis Completes Enrollment in Integument-Infant Phase 2 Study Evaluating Zoryve® (Roflumilast) Cream 0.05% in Infants With Atopic Dermatitis

THOMSON REUTERS

Arcutis Biotherapeutics Inc. Chief Medical Officer Patrick Burnett Reports Sale of Common Shares

H.C. Wainwright Sticks to Their Buy Rating for Arcutis Biotherapeutics (ARQT)

BRIEF-Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)

Director Howard G. Welgus Reports Disposal of Arcutis Biotherapeutics Inc. Common Shares

Arcutis Reports Positive Long-Term Safety Results for ZORYVE Foam in Seborrheic Dermatitis

A Look at Arcutis Biotherapeutics's Valuation Following Q3 Results and ZORYVE Launch for Pediatric Atopic Dermatitis

Simply Wall St.

Could Expanding ZORYVE to Younger Children Reshape Arcutis Biotherapeutics’ (ARQT) Long-Term Growth Narrative?

Simply Wall St.

Arcutis Biotherapeutics CEO Todd Watanabe Reports Sale of Common Shares

Stock Track | Arcutis Biotherapeutics Soars 5.49% on Zoryve Launch for Pediatric Atopic Dermatitis

Arcutis Launches Zoryve® (Roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5

THOMSON REUTERS

Arcutis Biotherapeutics (ARQT): Projected 24% Annual Revenue Growth Shapes Value Narrative Ahead of Earnings

Simply Wall St.

Morgan Stanley Raises Price Target on Arcutis Biotherapeutics to $32 From $21, Keeps Overweight Rating

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/ARQT/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ARQT","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARQT\",,,,,undefined,":{"symbol":"ARQT","market":"US","secType":"STK","nameCN":"Arcutis Biotherapeutics Inc.","latestPrice":23.63,"timestamp":1775160000000,"preClose":24.1,"halted":0,"volume":1092242,"hourTrading":{"tag":"盘后","latestPrice":23.2155,"preClose":23.63,"latestTime":"19:56 EDT","volume":454183,"amount":10732327.275,"timestamp":1775174213657,"change":-0.4145,"changeRate":-0.017541,"amplitude":0.031507},"delay":0,"changeRate":-0.01950207468879678,"floatShares":88242300,"shares":124033382,"eps":-0.12686,"marketStatus":"Market Closed","change":-0.47,"latestTime":"04-02 16:00:00 EDT","open":23.4,"high":24.08,"low":23.2,"amount":25835509.9833,"amplitude":0.036515,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.12686,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1775462400000},"marketStatusCode":7,"adr":0,"listingDate":1580446800000,"exchange":"NASDAQ","adjPreClose":24.1,"preHourTrading":{"tag":"盘前","latestPrice":24.1,"preClose":24.1,"latestTime":"08:30 EDT","volume":2597,"amount":61693.532124,"timestamp":1775133055204,"change":0,"changeRate":0,"amplitude":0.046058},"postHourTrading":{"tag":"盘后","latestPrice":23.2155,"preClose":23.63,"latestTime":"19:56 EDT","volume":454183,"amount":10732327.275,"timestamp":1775174213657,"change":-0.4145,"changeRate":-0.017541,"amplitude":0.031507},"volumeRatio":0.8156067717396938,"impliedVol":0.7233,"impliedVolPercentile":0.6892},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ARQT\",,,,,undefined,":{"symbol":"ARQT","floatShares":88242300,"roa":"-1.95%","roe":"-9.30%","lyrEps":-0.12686,"volumeRatio":0.8156067717396938,"shares":124033382,"dividePrice":0,"high":24.08,"amplitude":0.036515,"preClose":24.1,"low":23.2,"week52Low":11.86,"pbRate":"15.47","psRate":"7.79","week52High":31.77,"institutionHeld":0,"latestPrice":23.63,"eps":-0.12686,"divideRate":0,"volume":1092242,"delay":0,"ttmEps":-0.12686,"open":23.4,"prevYearClose":29.04,"prevWeekClose":21.22,"prevMonthClose":23.56,"prevQuarterClose":23.56,"fiveDayClose":22.38,"twentyDayClose":23.97,"sixtyDayClose":29.22},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ARQT\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-25","symbol":"ARQT","fiscalQuarterEnding":"2025/12","expectedEps":0.03,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1771995600000,"reportTimeType":"post","actualEps":0.13},{"market":"US","date":"2025-10-28","symbol":"ARQT","fiscalQuarterEnding":"2025/09","expectedEps":-0.1,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1761624000000,"reportTimeType":"pre","actualEps":0.06},{"market":"US","date":"2025-08-06","symbol":"ARQT","fiscalQuarterEnding":"2025/06","expectedEps":-0.18,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1754452800000,"reportTimeType":"post","actualEps":-0.13},{"market":"US","date":"2025-05-06","symbol":"ARQT","fiscalQuarterEnding":"2025/03","expectedEps":-0.21,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1746504000000,"reportTimeType":"post","actualEps":-0.2},{"market":"US","date":"2025-02-25","symbol":"ARQT","fiscalQuarterEnding":"2024/12","expectedEps":-0.27,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1740459600000,"reportTimeType":"post","actualEps":-0.09}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ARQT\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ARQT\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.625,"hold":0.125,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.625,"analysts":8,"updateTime":1753416000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ARQT\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ARQT","date":"2026-04-02","current":-186.268327,"percent":0.005686,"low":-219.54239,"twenty":-12.401971,"median":-5.215051,"eighty":-2.887774,"high":-0.601968,"avg":-14.70869,"sd":30.369702,"marketCap":2989204506},"quantilePoints":[{"date":"2021-04-09","current":-9.826605,"twenty":-22.899342,"median":-12.934795,"eighty":-10.429134,"marketCap":1333254101},{"date":"2021-04-16","current":-10.158834,"twenty":-22.850543,"median":-12.912646,"eighty":-10.407126,"marketCap":1378330311},{"date":"2021-04-23","current":-10.694093,"twenty":-22.794515,"median":-12.62656,"eighty":-10.407126,"marketCap":1450953092},{"date":"2021-04-30","current":-12.382379,"twenty":-22.683358,"median":-12.382379,"eighty":-10.413279,"marketCap":1680016424},{"date":"2021-05-07","current":-11.923554,"twenty":-22.288437,"median":-12.267268,"eighty":-10.422764,"marketCap":1713498219},{"date":"2021-05-14","current":-8.995943,"twenty":-22.136633,"median":-12.104826,"eighty":-10.393528,"marketCap":1292779934},{"date":"2021-05-21","current":-8.8562,"twenty":-22.093598,"median":-11.993479,"eighty":-10.384067,"marketCap":1272697916},{"date":"2021-05-28","current":-9.205557,"twenty":-21.670284,"median":-11.938107,"eighty":-10.356031,"marketCap":1322902962},{"date":"2021-06-04","current":-9.216038,"twenty":-20.43425,"median":-11.886427,"eighty":-10.332332,"marketCap":1324409113},{"date":"2021-06-11","current":-9.907764,"twenty":-20.348461,"median":-11.669666,"eighty":-10.26818,"marketCap":1423815104},{"date":"2021-06-18","current":-9.554914,"twenty":-20.320025,"median":-11.596345,"eighty":-10.192338,"marketCap":1373108008},{"date":"2021-06-25","current":-9.568888,"twenty":-20.199466,"median":-11.580493,"eighty":-10.158834,"marketCap":1375116209},{"date":"2021-07-02","current":-9.205557,"twenty":-20.169729,"median":-11.497915,"eighty":-10.113424,"marketCap":1322902962},{"date":"2021-07-09","current":-9.254467,"twenty":-20.16011,"median":-11.469014,"eighty":-10.050136,"marketCap":1329931668},{"date":"2021-07-16","current":-8.943539,"twenty":-19.907612,"median":-11.413123,"eighty":-9.94087,"marketCap":1285249177},{"date":"2021-07-23","current":-8.517324,"twenty":-19.719919,"median":-11.396025,"eighty":-9.892043,"marketCap":1223999021},{"date":"2021-07-30","current":-8.150499,"twenty":-19.669512,"median":-11.376135,"eighty":-9.823833,"marketCap":1171283723},{"date":"2021-08-06","current":-7.170092,"twenty":-19.563735,"median":-11.32902,"eighty":-9.755214,"marketCap":1077686374},{"date":"2021-08-13","current":-6.84585,"twenty":-19.524057,"median":-11.29475,"eighty":-9.682522,"marketCap":1028951838},{"date":"2021-08-20","current":-6.768968,"twenty":-19.486784,"median":-11.284722,"eighty":-9.566792,"marketCap":1017396227},{"date":"2021-08-27","current":-7.250317,"twenty":-19.420653,"median":-11.269281,"eighty":-9.533019,"marketCap":1089744403},{"date":"2021-09-03","current":-7.236946,"twenty":-19.276369,"median":-11.234005,"eighty":-9.46478,"marketCap":1087734731},{"date":"2021-09-10","current":-7.069811,"twenty":-19.240298,"median":-11.181362,"eighty":-9.371152,"marketCap":1062613837},{"date":"2021-09-17","current":-7.577902,"twenty":-19.176572,"median":-11.175871,"eighty":-9.262153,"marketCap":1138981356},{"date":"2021-09-24","current":-7.748379,"twenty":-18.991408,"median":-11.158719,"eighty":-9.211846,"marketCap":1164604669},{"date":"2021-10-01","current":-8.426948,"twenty":-18.862754,"median":-11.111307,"eighty":-9.10564,"marketCap":1266595500},{"date":"2021-10-08","current":-7.467593,"twenty":-18.790612,"median":-11.079463,"eighty":-8.987558,"marketCap":1122401566},{"date":"2021-10-15","current":-7.447536,"twenty":-18.504449,"median":-11.034733,"eighty":-8.896023,"marketCap":1119387058},{"date":"2021-10-22","current":-7.210205,"twenty":-18.242332,"median":-11.017566,"eighty":-8.820821,"marketCap":1083715388},{"date":"2021-10-29","current":-7.079839,"twenty":-18.165381,"median":-11.007935,"eighty":-8.754886,"marketCap":1064121091},{"date":"2021-11-05","current":-6.559128,"twenty":-18.076405,"median":-10.979417,"eighty":-8.692002,"marketCap":1109010879},{"date":"2021-11-12","current":-6.303308,"twenty":-18.01268,"median":-10.956178,"eighty":-8.521261,"marketCap":1065756940},{"date":"2021-11-19","current":-5.410909,"twenty":-17.90086,"median":-10.948897,"eighty":-8.393247,"marketCap":914871106},{"date":"2021-11-26","current":-4.958761,"twenty":-17.811884,"median":-10.868783,"eighty":-8.205598,"marketCap":838422284},{"date":"2021-12-03","current":-4.572055,"twenty":-17.754171,"median":-10.821143,"eighty":-8.128839,"marketCap":773038422},{"date":"2021-12-10","current":-4.554207,"twenty":-17.686838,"median":-10.761965,"eighty":-7.988352,"marketCap":770020706},{"date":"2021-12-17","current":-5.077747,"twenty":-17.648362,"median":-10.740982,"eighty":-7.959145,"marketCap":858540395},{"date":"2021-12-23","current":-5.979069,"twenty":-17.635136,"median":-10.714699,"eighty":-7.901858,"marketCap":1010935087},{"date":"2021-12-31","current":-6.169448,"twenty":-17.589446,"median":-10.693296,"eighty":-7.750385,"marketCap":1043124065},{"date":"2022-01-07","current":-5.550718,"twenty":-17.546161,"median":-10.643177,"eighty":-7.597958,"marketCap":938509887},{"date":"2022-01-14","current":-5.178886,"twenty":-17.48484,"median":-10.587041,"eighty":-7.559851,"marketCap":875640789},{"date":"2022-01-21","current":-4.580979,"twenty":-17.470412,"median":-10.567335,"eighty":-7.447536,"marketCap":774547281},{"date":"2022-01-28","current":-4.363828,"twenty":-17.4644,"median":-10.537841,"eighty":-7.387368,"marketCap":737831728},{"date":"2022-02-04","current":-4.405474,"twenty":-17.434341,"median":-10.449358,"eighty":-7.317171,"marketCap":744873067},{"date":"2022-02-11","current":-4.601801,"twenty":-17.428329,"median":-10.423257,"eighty":-7.280401,"marketCap":778067950},{"date":"2022-02-18","current":-4.753509,"twenty":-17.416305,"median":-10.40616,"eighty":-7.257002,"marketCap":803718542},{"date":"2022-02-25","current":-4.392122,"twenty":-17.401877,"median":-10.39037,"eighty":-7.236278,"marketCap":906340769},{"date":"2022-03-04","current":-4.099151,"twenty":-17.186653,"median":-10.384149,"eighty":-7.159812,"marketCap":845884464},{"date":"2022-03-11","current":-4.1138,"twenty":-17.104892,"median":-10.36521,"eighty":-7.079171,"marketCap":848907279},{"date":"2022-03-18","current":-4.13089,"twenty":-17.033282,"median":-10.35086,"eighty":-7.04307,"marketCap":852433897},{"date":"2022-03-25","current":-4.196808,"twenty":-17.017183,"median":-10.332332,"eighty":-6.947015,"marketCap":866036566},{"date":"2022-04-01","current":-4.965857,"twenty":-17.009437,"median":-10.282581,"eighty":-6.851199,"marketCap":1024734366},{"date":"2022-04-08","current":-5.153847,"twenty":-16.959406,"median":-10.265886,"eighty":-6.753772,"marketCap":1063527161},{"date":"2022-04-14","current":-5.134315,"twenty":-16.882454,"median":-10.227872,"eighty":-6.5859,"marketCap":1059496741},{"date":"2022-04-22","current":-5.028274,"twenty":-16.82474,"median":-10.168371,"eighty":-6.49195,"marketCap":1037614493},{"date":"2022-04-29","current":-5.030766,"twenty":-16.782657,"median":-10.158834,"eighty":-6.312232,"marketCap":1038128672},{"date":"2022-05-06","current":-4.251266,"twenty":-16.696086,"median":-10.12128,"eighty":-6.093891,"marketCap":997508482},{"date":"2022-05-13","current":-3.929134,"twenty":-16.623945,"median":-10.10466,"eighty":-6.000487,"marketCap":921924076},{"date":"2022-05-20","current":-4.527379,"twenty":-16.597493,"median":-10.032757,"eighty":-5.701236,"marketCap":1062295115},{"date":"2022-05-27","current":-4.599694,"twenty":-16.581861,"median":-9.947741,"eighty":-5.53644,"marketCap":1079263043},{"date":"2022-06-03","current":-4.647904,"twenty":-16.572243,"median":-9.937348,"eighty":-5.380167,"marketCap":1090574995},{"date":"2022-06-10","current":-4.623799,"twenty":-16.501303,"median":-9.901868,"eighty":-5.305352,"marketCap":1084919019},{"date":"2022-06-17","current":-4.634756,"twenty":-16.287281,"median":-9.834399,"eighty":-5.210156,"marketCap":1087489917},{"date":"2022-06-24","current":-4.516422,"twenty":-16.104521,"median":-9.823919,"eighty":-5.174012,"marketCap":1059724217},{"date":"2022-07-01","current":-4.761856,"twenty":-16.026367,"median":-9.798403,"eighty":-5.084178,"marketCap":1117312335},{"date":"2022-07-08","current":-5.588004,"twenty":-15.925369,"median":-9.746482,"eighty":-5.07328,"marketCap":1311158056},{"date":"2022-07-15","current":-5.303125,"twenty":-15.91623,"median":-9.719112,"eighty":-5.07328,"marketCap":1244314704},{"date":"2022-07-22","current":-4.715837,"twenty":-15.564658,"median":-9.592702,"eighty":-5.07328,"marketCap":1106514563},{"date":"2022-07-29","current":-5.316274,"twenty":-15.554693,"median":-9.568888,"eighty":-5.045026,"marketCap":1247399782},{"date":"2022-08-05","current":-5.095799,"twenty":-15.511653,"median":-9.54618,"eighty":-5.035749,"marketCap":1325091253},{"date":"2022-08-12","current":-5.81655,"twenty":-15.450433,"median":-9.529289,"eighty":-5.039076,"marketCap":1512512503},{"date":"2022-08-19","current":-5.943853,"twenty":-15.366267,"median":-9.471951,"eighty":-5.045026,"marketCap":1545615642},{"date":"2022-08-26","current":-5.661473,"twenty":-15.363261,"median":-9.450107,"eighty":-5.073125,"marketCap":1472186861},{"date":"2022-09-02","current":-5.580463,"twenty":-15.348232,"median":-9.341806,"eighty":-5.07328,"marketCap":1451121227},{"date":"2022-09-09","current":-4.728696,"twenty":-15.304946,"median":-9.300061,"eighty":-5.043836,"marketCap":1229631135},{"date":"2022-09-16","current":-4.131533,"twenty":-15.137599,"median":-9.254467,"eighty":-5.029962,"marketCap":1074347321},{"date":"2022-09-23","current":-4.210229,"twenty":-15.084695,"median":-9.210797,"eighty":-5.001449,"marketCap":1094811079},{"date":"2022-09-30","current":-4.423171,"twenty":-15.033047,"median":-9.163634,"eighty":-4.978112,"marketCap":1150183602},{"date":"2022-10-07","current":-4.430114,"twenty":-15.013454,"median":-9.022191,"eighty":-4.953727,"marketCap":1151989228},{"date":"2022-10-14","current":-4.314385,"twenty":-14.988121,"median":-8.988956,"eighty":-4.912951,"marketCap":1121895466},{"date":"2022-10-21","current":-4.045893,"twenty":-14.920281,"median":-8.934805,"eighty":-4.879762,"marketCap":1052077937},{"date":"2022-10-28","current":-4.050523,"twenty":-14.860357,"median":-8.887642,"eighty":-4.851696,"marketCap":1053281687},{"date":"2022-11-04","current":-4.161623,"twenty":-14.777107,"median":-8.838732,"eighty":-4.821023,"marketCap":1082171699},{"date":"2022-11-11","current":-3.74156,"twenty":-14.629216,"median":-8.782835,"eighty":-4.767826,"marketCap":1162745956},{"date":"2022-11-18","current":-3.669042,"twenty":-14.567894,"median":-8.753139,"eighty":-4.759458,"marketCap":1140209759},{"date":"2022-11-25","current":-3.522045,"twenty":-14.103561,"median":-8.70947,"eighty":-4.744509,"marketCap":1094528278},{"date":"2022-12-02","current":-3.431887,"twenty":-13.679557,"median":-8.692002,"eighty":-4.724743,"marketCap":1066510303},{"date":"2022-12-09","current":-3.331929,"twenty":-13.444532,"median":-8.527592,"eighty":-4.700106,"marketCap":1035446897},{"date":"2022-12-16","current":-3.128093,"twenty":-13.276622,"median":-8.473649,"eighty":-4.681644,"marketCap":972101910},{"date":"2022-12-23","current":-2.80274,"twenty":-13.191719,"median":-8.384936,"eighty":-4.645231,"marketCap":870993566},{"date":"2022-12-30","current":-2.900738,"twenty":-13.151671,"median":-8.26928,"eighty":-4.621309,"marketCap":901447886},{"date":"2023-01-06","current":-2.941897,"twenty":-13.122655,"median":-8.163986,"eighty":-4.611636,"marketCap":914238701},{"date":"2023-01-13","current":-2.767461,"twenty":-13.049801,"median":-8.133031,"eighty":-4.600115,"marketCap":860030010},{"date":"2023-01-20","current":-3.182972,"twenty":-12.934795,"median":-8.076242,"eighty":-4.582877,"marketCap":989156329},{"date":"2023-01-27","current":-3.245691,"twenty":-12.934795,"median":-7.989013,"eighty":-4.572055,"marketCap":1008647094},{"date":"2023-02-03","current":-3.26725,"twenty":-12.920029,"median":-7.979314,"eighty":-4.516422,"marketCap":1015347045},{"date":"2023-02-10","current":-3.26529,"twenty":-12.912646,"median":-7.948441,"eighty":-4.503274,"marketCap":1014737959},{"date":"2023-02-17","current":-3.326049,"twenty":-12.908955,"median":-7.895458,"eighty":-4.485789,"marketCap":1033619637},{"date":"2023-02-24","current":-3.069295,"twenty":-12.857317,"median":-7.868717,"eighty":-4.450483,"marketCap":953829318},{"date":"2023-03-03","current":-3.049652,"twenty":-12.680466,"median":-7.728323,"eighty":-4.437802,"marketCap":949838659},{"date":"2023-03-10","current":-2.37108,"twenty":-12.618808,"median":-7.63807,"eighty":-4.40667,"marketCap":738491922},{"date":"2023-03-17","current":-2.174961,"twenty":-12.471889,"median":-7.577902,"eighty":-4.38775,"marketCap":677409050},{"date":"2023-03-24","current":-2.006299,"twenty":-12.393193,"median":-7.557845,"eighty":-4.361038,"marketCap":624877780},{"date":"2023-03-31","current":-2.15731,"twenty":-12.352805,"median":-7.457565,"eighty":-4.339559,"marketCap":671911592},{"date":"2023-04-06","current":-2.174961,"twenty":-12.251639,"median":-7.439179,"eighty":-4.317081,"marketCap":677409050},{"date":"2023-04-14","current":-2.890796,"twenty":-12.149257,"median":-7.387368,"eighty":-4.302982,"marketCap":900361533},{"date":"2023-04-21","current":-2.64981,"twenty":-12.111967,"median":-7.345584,"eighty":-4.287073,"marketCap":825304589},{"date":"2023-04-28","current":-2.710884,"twenty":-12.051307,"median":-7.307143,"eighty":-4.275809,"marketCap":844326479},{"date":"2023-05-05","current":-2.852732,"twenty":-12.013412,"median":-7.285415,"eighty":-4.272631,"marketCap":888506353},{"date":"2023-05-12","current":-2.030776,"twenty":-11.989787,"median":-7.273716,"eighty":-4.23106,"marketCap":664538936},{"date":"2023-05-19","current":-1.773778,"twenty":-11.963634,"median":-7.253659,"eighty":-4.213006,"marketCap":580440564},{"date":"2023-05-26","current":-1.572938,"twenty":-11.945281,"median":-7.236946,"eighty":-4.158119,"marketCap":514718723},{"date":"2023-06-02","current":-1.435916,"twenty":-11.932286,"median":-7.210205,"eighty":-4.134311,"marketCap":469880457},{"date":"2023-06-09","current":-1.878891,"twenty":-11.908703,"median":-7.144392,"eighty":-4.110552,"marketCap":614837042},{"date":"2023-06-16","current":-1.918308,"twenty":-11.884629,"median":-7.103238,"eighty":-4.057929,"marketCap":627735722},{"date":"2023-06-23","current":-1.741869,"twenty":-11.848545,"median":-7.076497,"eighty":-4.026885,"marketCap":569998776},{"date":"2023-06-30","current":-1.563553,"twenty":-11.714996,"median":-7.05644,"eighty":-3.967314,"marketCap":511647609},{"date":"2023-07-07","current":-1.745623,"twenty":-11.642467,"median":-7.04307,"eighty":-3.925051,"marketCap":571227222},{"date":"2023-07-14","current":-1.762516,"twenty":-11.614497,"median":-6.969247,"eighty":-3.848691,"marketCap":576755227},{"date":"2023-07-21","current":-1.944587,"twenty":-11.599484,"median":-6.88262,"eighty":-3.826122,"marketCap":636334841},{"date":"2023-07-28","current":-1.877014,"twenty":-11.593683,"median":-6.849193,"eighty":-3.729016,"marketCap":614222820},{"date":"2023-08-04","current":-1.899538,"twenty":-11.588195,"median":-6.768968,"eighty":-3.661986,"marketCap":621593493},{"date":"2023-08-11","current":-1.729492,"twenty":-11.576596,"median":-6.672481,"eighty":-3.558108,"marketCap":572148915},{"date":"2023-08-18","current":-1.513306,"twenty":-11.543391,"median":-6.559128,"eighty":-3.396999,"marketCap":500630301},{"date":"2023-08-25","current":-1.397758,"twenty":-11.50548,"median":-6.539234,"eighty":-3.357016,"marketCap":462404835},{"date":"2023-09-01","current":-1.59158,"twenty":-11.482698,"median":-6.41337,"eighty":-3.331929,"marketCap":526524972},{"date":"2023-09-08","current":-1.410804,"twenty":-11.472966,"median":-6.318181,"eighty":-3.324089,"marketCap":466720613},{"date":"2023-09-15","current":-1.263573,"twenty":-11.45451,"median":-6.233373,"eighty":-3.276697,"marketCap":418013970},{"date":"2023-09-22","current":-1.06416,"twenty":-11.42629,"median":-6.169448,"eighty":-3.258626,"marketCap":352044214},{"date":"2023-09-29","current":-1.032477,"twenty":-11.412962,"median":-6.063847,"eighty":-3.243339,"marketCap":341563038},{"date":"2023-10-06","current":-0.825609,"twenty":-11.409469,"median":-6.015605,"eighty":-3.209235,"marketCap":273127122},{"date":"2023-10-13","current":-0.723107,"twenty":-11.400642,"median":-5.976506,"eighty":-3.17241,"marketCap":239217434},{"date":"2023-10-20","current":-0.862364,"twenty":-11.394391,"median":-5.943853,"eighty":-3.144949,"marketCap":285286553},{"date":"2023-10-27","current":-0.674523,"twenty":-11.393302,"median":-5.897561,"eighty":-3.132013,"marketCap":223144927},{"date":"2023-11-03","current":-0.631831,"twenty":-11.3807,"median":-5.832752,"eighty":-3.102605,"marketCap":209021831},{"date":"2023-11-10","current":-0.704673,"twenty":-11.37157,"median":-5.807292,"eighty":-3.047735,"marketCap":188764148},{"date":"2023-11-17","current":-0.687056,"twenty":-11.346823,"median":-5.756372,"eighty":-2.919717,"marketCap":184045044},{"date":"2023-11-24","current":-0.715243,"twenty":-11.332581,"median":-5.74827,"eighty":-2.89004,"marketCap":191595610},{"date":"2023-12-01","current":-0.648299,"twenty":-11.314858,"median":-5.661473,"eighty":-2.85821,"marketCap":173663016},{"date":"2023-12-08","current":-0.77514,"twenty":-11.299109,"median":-5.61116,"eighty":-2.829879,"marketCap":207640562},{"date":"2023-12-15","current":-0.894934,"twenty":-11.293967,"median":-5.604262,"eighty":-2.79098,"marketCap":239730467},{"date":"2023-12-22","current":-0.916074,"twenty":-11.292281,"median":-5.578714,"eighty":-2.755309,"marketCap":245393392},{"date":"2023-12-29","current":-1.16271,"twenty":-11.289083,"median":-5.550718,"eighty":-2.739778,"marketCap":311460844},{"date":"2024-01-05","current":-1.423438,"twenty":-11.284722,"median":-5.517653,"eighty":-2.726645,"marketCap":381303578},{"date":"2024-01-12","current":-1.303644,"twenty":-11.275195,"median":-5.468205,"eighty":-2.710884,"marketCap":349213673},{"date":"2024-01-19","current":-1.15214,"twenty":-11.273957,"median":-5.410909,"eighty":-2.683375,"marketCap":308629381},{"date":"2024-01-26","current":-1.705307,"twenty":-11.26666,"median":-5.338123,"eighty":-2.63862,"marketCap":456809238},{"date":"2024-02-02","current":-2.339513,"twenty":-11.245892,"median":-5.316274,"eighty":-2.5217,"marketCap":626696971},{"date":"2024-02-09","current":-2.008317,"twenty":-11.235431,"median":-5.300252,"eighty":-2.355353,"marketCap":537977821},{"date":"2024-02-16","current":-2.80812,"twenty":-11.215339,"median":-5.274637,"eighty":-2.353607,"marketCap":752225129},{"date":"2024-02-23","current":-3.389475,"twenty":-11.193086,"median":-5.243958,"eighty":-2.35844,"marketCap":907955551},{"date":"2024-03-01","current":-4.415798,"twenty":-11.179221,"median":-5.210536,"eighty":-2.366373,"marketCap":1157557164},{"date":"2024-03-08","current":-4.552536,"twenty":-11.17772,"median":-5.178886,"eighty":-2.404028,"marketCap":1193401658},{"date":"2024-03-15","current":-4.798144,"twenty":-11.175512,"median":-5.16332,"eighty":-2.42907,"marketCap":1257785562},{"date":"2024-03-22","current":-4.464818,"twenty":-11.171802,"median":-5.11905,"eighty":-2.470406,"marketCap":1170407406},{"date":"2024-03-28","current":-4.206052,"twenty":-11.16566,"median":-5.109901,"eighty":-2.509149,"marketCap":1102574364},{"date":"2024-04-05","current":-4.714813,"twenty":-11.145495,"median":-5.075513,"eighty":-2.557002,"marketCap":1235941023},{"date":"2024-04-12","current":-5.210416,"twenty":-11.12515,"median":-5.095799,"eighty":-2.606851,"marketCap":1365858545},{"date":"2024-04-19","current":-4.144649,"twenty":-11.113923,"median":-5.07328,"eighty":-2.62341,"marketCap":1086478388},{"date":"2024-04-26","current":-3.767464,"twenty":-11.091906,"median":-5.05583,"eighty":-2.636335,"marketCap":987603106},{"date":"2024-05-03","current":-3.790016,"twenty":-11.081237,"median":-5.037413,"eighty":-2.643782,"marketCap":993514905},{"date":"2024-05-10","current":-3.534411,"twenty":-11.066745,"median":-5.030152,"eighty":-2.650615,"marketCap":926510411},{"date":"2024-05-17","current":-4.855853,"twenty":-11.046309,"median":-5.025142,"eighty":-2.659377,"marketCap":1055769175},{"date":"2024-05-24","current":-4.834555,"twenty":-11.036641,"median":-5.02201,"eighty":-2.673382,"marketCap":1051138609},{"date":"2024-05-31","current":-4.61093,"twenty":-11.024634,"median":-4.987567,"eighty":-2.678888,"marketCap":1002517660},{"date":"2024-06-07","current":-4.046544,"twenty":-11.021424,"median":-4.981441,"eighty":-2.688453,"marketCap":879807646},{"date":"2024-06-14","current":-4.972989,"twenty":-11.017566,"median":-4.975947,"eighty":-2.702782,"marketCap":1081237291},{"date":"2024-06-21","current":-4.408603,"twenty":-11.012758,"median":-4.972608,"eighty":-2.705918,"marketCap":958527277},{"date":"2024-06-28","current":-5.015585,"twenty":-11.011194,"median":-4.972608,"eighty":-2.707538,"marketCap":1090498424},{"date":"2024-07-05","current":-5.111424,"twenty":-11.009747,"median":-4.973284,"eighty":-2.710884,"marketCap":1111335974},{"date":"2024-07-12","current":-5.713081,"twenty":-11.006122,"median":-4.979583,"eighty":-2.718764,"marketCap":1242149479},{"date":"2024-07-15","current":-5.654513,"twenty":-11.000819,"median":-4.981441,"eighty":-2.719552,"marketCap":1229415421},{"date":"2024-08-02","current":-5.047531,"twenty":-10.995515,"median":-4.9833,"eighty":-2.72034,"marketCap":1097444274},{"date":"2024-08-09","current":-4.760013,"twenty":-10.97953,"median":-4.975947,"eighty":-2.723261,"marketCap":1034931626},{"date":"2024-08-16","current":-4.998786,"twenty":-10.978983,"median":-4.9833,"eighty":-2.725115,"marketCap":993573695},{"date":"2024-08-23","current":-4.892929,"twenty":-10.969611,"median":-4.981441,"eighty":-2.730428,"marketCap":972533311},{"date":"2024-08-30","current":-6.469017,"twenty":-10.956248,"median":-4.987567,"eighty":-2.737048,"marketCap":1285801253},{"date":"2024-09-06","current":-6.369041,"twenty":-10.955236,"median":-4.998786,"eighty":-2.739122,"marketCap":1265929779},{"date":"2024-09-13","current":-6.186733,"twenty":-10.952072,"median":-5.018797,"eighty":-2.744144,"marketCap":1229693561},{"date":"2024-09-20","current":-5.963258,"twenty":-10.943556,"median":-5.029203,"eighty":-2.754133,"marketCap":1185274973},{"date":"2024-09-27","current":-5.386927,"twenty":-10.911511,"median":-5.033257,"eighty":-2.758053,"marketCap":1070721770},{"date":"2024-10-04","current":-5.983841,"twenty":-10.864968,"median":-5.045026,"eighty":-2.769421,"marketCap":1189366159},{"date":"2024-10-11","current":-5.751544,"twenty":-10.844638,"median":-5.050193,"eighty":-2.778437,"marketCap":1143194204},{"date":"2024-10-18","current":-5.580998,"twenty":-10.823071,"median":-5.073125,"eighty":-2.785101,"marketCap":1109295808},{"date":"2024-10-25","current":-4.945858,"twenty":-10.815844,"median":-5.054343,"eighty":-2.79426,"marketCap":983053503},{"date":"2024-10-31","current":-5.010548,"twenty":-10.807502,"median":-5.054343,"eighty":-2.799539,"marketCap":995911515},{"date":"2024-11-08","current":-6.225299,"twenty":-10.761965,"median":-5.07328,"eighty":-2.80274,"marketCap":1217263746},{"date":"2024-11-15","current":-5.943963,"twenty":-10.754335,"median":-5.082373,"eighty":-2.80812,"marketCap":1162252788},{"date":"2024-11-22","current":-6.129525,"twenty":-10.74289,"median":-5.095799,"eighty":-2.80939,"marketCap":1198536611},{"date":"2024-11-29","current":-7.805567,"twenty":-10.739838,"median":-5.109901,"eighty":-2.829879,"marketCap":1526261466},{"date":"2024-12-06","current":-7.368599,"twenty":-10.732971,"median":-5.112171,"eighty":-2.837415,"marketCap":1440818915},{"date":"2024-12-13","current":-7.332683,"twenty":-10.704651,"median":-5.122285,"eighty":-2.848861,"marketCap":1433796239},{"date":"2024-12-20","current":-8.446054,"twenty":-10.694865,"median":-5.131241,"eighty":-2.8525,"marketCap":1651499179},{"date":"2024-12-27","current":-8.936895,"twenty":-10.693615,"median":-5.149828,"eighty":-2.85684,"marketCap":1747475743},{"date":"2025-01-03","current":-8.715418,"twenty":-10.687708,"median":-5.171392,"eighty":-2.863145,"marketCap":1704169244},{"date":"2025-01-10","current":-9.140414,"twenty":-10.673782,"median":-5.178886,"eighty":-2.869846,"marketCap":1787270904},{"date":"2025-01-17","current":-8.230563,"twenty":-10.648233,"median":-5.208632,"eighty":-2.877611,"marketCap":1609363126},{"date":"2025-01-24","current":-8.140775,"twenty":-10.63475,"median":-5.212441,"eighty":-2.887018,"marketCap":1591806437},{"date":"2025-01-31","current":-8.182676,"twenty":-10.582611,"median":-5.220449,"eighty":-2.889285,"marketCap":1599999558},{"date":"2025-02-07","current":-7.434443,"twenty":-10.512422,"median":-5.220449,"eighty":-2.889285,"marketCap":1453693820},{"date":"2025-02-14","current":-7.368599,"twenty":-10.415568,"median":-5.220449,"eighty":-2.889285,"marketCap":1440818915},{"date":"2025-02-21","current":-8.033029,"twenty":-10.387842,"median":-5.220449,"eighty":-2.889285,"marketCap":1570738411},{"date":"2025-02-28","current":-10.843904,"twenty":-10.375152,"median":-5.220449,"eighty":-2.889285,"marketCap":1518569408},{"date":"2025-03-07","current":-12.284109,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1720254407},{"date":"2025-03-14","current":-12.546735,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1757032260},{"date":"2025-03-21","current":-14.207208,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1989563200},{"date":"2025-03-28","current":-13.631126,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1908889201},{"date":"2025-04-04","current":-13.690428,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1917193877},{"date":"2025-04-11","current":-11.386099,"twenty":-10.375152,"median":-5.220449,"eighty":-2.889285,"marketCap":1594497878},{"date":"2025-04-17","current":-10.979452,"twenty":-10.375152,"median":-5.220449,"eighty":-2.889285,"marketCap":1537551525},{"date":"2025-04-25","current":-12.470489,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1746354819},{"date":"2025-05-02","current":-12.411186,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1738050142},{"date":"2025-05-09","current":-12.419431,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1611011299},{"date":"2025-05-16","current":-12.525108,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1624719498},{"date":"2025-05-23","current":-12.552677,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1628295549},{"date":"2025-05-30","current":-12.561866,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1629487567},{"date":"2025-06-06","current":-12.414836,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1610415291},{"date":"2025-06-13","current":-12.405647,"twenty":-10.367632,"median":-5.217662,"eighty":-2.888529,"marketCap":1609223274},{"date":"2025-06-20","current":-12.561866,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1629487567},{"date":"2025-06-27","current":-13.23269,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1716504825},{"date":"2025-07-03","current":-12.699706,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1647367825},{"date":"2025-07-11","current":-14.032165,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1820210325},{"date":"2025-07-18","current":-14.225142,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1845242687},{"date":"2025-07-25","current":-13.802431,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1790409894},{"date":"2025-08-01","current":-13.398098,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1737961135},{"date":"2025-08-08","current":-18.152048,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1693059701},{"date":"2025-08-15","current":-20.543182,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1916083146},{"date":"2025-08-22","current":-20.298927,"twenty":-10.365186,"median":-5.215051,"eighty":-2.887774,"marketCap":1893301181},{"date":"2025-08-29","current":-19.91326,"twenty":-10.381059,"median":-5.215051,"eighty":-2.887774,"marketCap":1857329658},{"date":"2025-09-05","current":-20.83886,"twenty":-10.384012,"median":-5.212441,"eighty":-2.887018,"marketCap":1943661314},{"date":"2025-09-12","current":-22.741483,"twenty":-10.420146,"median":-5.215051,"eighty":-2.887774,"marketCap":2121120829},{"date":"2025-09-19","current":-22.767194,"twenty":-10.423749,"median":-5.215051,"eighty":-2.887774,"marketCap":2123518931},{"date":"2025-09-26","current":-21.507349,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2006011954},{"date":"2025-10-03","current":-27.318061,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2547982907},{"date":"2025-10-10","current":-26.623861,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2483234165},{"date":"2025-10-17","current":-26.880972,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2507215180},{"date":"2025-10-24","current":-25.813961,"twenty":-10.565631,"median":-5.215051,"eighty":-2.887774,"marketCap":2407693966},{"date":"2025-10-31","current":-68.868004,"twenty":-10.690502,"median":-5.215051,"eighty":-2.887774,"marketCap":3052505424},{"date":"2025-11-07","current":-69.365446,"twenty":-10.752046,"median":-5.215051,"eighty":-2.887774,"marketCap":3074554019},{"date":"2025-11-14","current":-63.175063,"twenty":-10.869212,"median":-5.215051,"eighty":-2.887774,"marketCap":2800171509},{"date":"2025-11-21","current":-75.528193,"twenty":-10.975168,"median":-5.215051,"eighty":-2.887774,"marketCap":3347711607},{"date":"2025-11-28","current":-84.703224,"twenty":-11.010469,"median":-5.215051,"eighty":-2.887774,"marketCap":3754385684},{"date":"2025-12-05","current":-86.112641,"twenty":-11.07479,"median":-5.215051,"eighty":-2.887774,"marketCap":3816856702},{"date":"2025-12-12","current":-81.442219,"twenty":-11.173501,"median":-5.215051,"eighty":-2.887774,"marketCap":3609844898},{"date":"2025-12-19","current":-76.771796,"twenty":-11.177769,"median":-5.215051,"eighty":-2.887774,"marketCap":3402833093},{"date":"2025-12-26","current":-81.386947,"twenty":-11.196048,"median":-5.215051,"eighty":-2.887774,"marketCap":3607395054},{"date":"2026-01-02","current":-80.253886,"twenty":-11.282507,"median":-5.215051,"eighty":-2.887774,"marketCap":3557173255},{"date":"2026-01-09","current":-82.57528,"twenty":-11.378874,"median":-5.215051,"eighty":-2.887774,"marketCap":3660066696},{"date":"2026-01-16","current":-72.847536,"twenty":-11.521061,"median":-5.215051,"eighty":-2.887774,"marketCap":3228894181},{"date":"2026-01-23","current":-73.648969,"twenty":-11.696864,"median":-5.215051,"eighty":-2.887774,"marketCap":3264416916},{"date":"2026-01-30","current":-71.106491,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3151724100},{"date":"2026-02-06","current":-72.046102,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3193371445},{"date":"2026-02-13","current":-73.814783,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3271766448},{"date":"2026-02-20","current":-77.241602,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3423656766},{"date":"2026-02-27","current":-219.54239,"twenty":-11.967638,"median":-5.215051,"eighty":-2.887774,"marketCap":3543633723},{"date":"2026-03-06","current":-184.194298,"twenty":-12.014889,"median":-5.215051,"eighty":-2.887774,"marketCap":2973080166},{"date":"2026-03-13","current":-176.048868,"twenty":-12.184571,"median":-5.215051,"eighty":-2.887774,"marketCap":2841604781},{"date":"2026-03-20","current":-176.048868,"twenty":-12.300473,"median":-5.215051,"eighty":-2.887774,"marketCap":2841604781},{"date":"2026-03-27","current":-171.976153,"twenty":-12.370522,"median":-5.215051,"eighty":-2.887774,"marketCap":2775867089},{"date":"2026-04-02","current":-185.193266,"twenty":-12.401971,"median":-5.215051,"eighty":-2.887774,"marketCap":2989204506}],"updateTime":1775333969544},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ARQT\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2584253306","title":"Arcutis Biotherapeutics Inc - FDA Sets Pdufa Target Date for June 29, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2584253306","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584253306?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:00","pubTimestamp":1763384404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nTUA6M2QKK:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584162580","title":"FDA Accepts Supplemental New Drug Application for Arcutis’ Zoryve® (Roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children Ages 2 to 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2584162580","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584162580?lang=en_us&edition=fundamental","pubTime":"2025-11-17 21:00","pubTimestamp":1763384404,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251117:nTUA6M2QKK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583511686","title":"Executive VP & Chief Commercial Officer Of Arcutis Biotherapeutics Sold 40% Of Their Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2583511686","media":"Simply Wall St.","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583511686?lang=en_us&edition=fundamental","pubTime":"2025-11-14 03:03","pubTimestamp":1763060619,"startTime":"0","endTime":"0","summary":"We wouldn't blame Arcutis Biotherapeutics, Inc. ( NASDAQ:ARQT ) shareholders if they were a little worried about the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/executive-vp-chief-commercial-officer-of-arcutis-biotherapeu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/executive-vp-chief-commercial-officer-of-arcutis-biotherapeu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583593067","title":"Arcutis Biotherapeutics Completes Enrollment for Phase 2 Study of Investigational Treatment for Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2583593067","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583593067?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:48","pubTimestamp":1763041692,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics  said Thursday it has completed enrollment for its phase 2 open-label clinical study evaluating the safety and tolerability of investigational Zoryve cream 0.05% in infants aged three months to less than 24 months with mild to moderate atopic dermatitis.The company said it expects to report topline results from the study in Q1 of 2026.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583598728","title":"BRIEF-Arcutis Canada Says Health Canada Approves ZORYVE Foam 0.3% For Scalp, Body Psoriasis For Adults & Adolescents 12 & Older","url":"https://stock-news.laohu8.com/highlight/detail?id=2583598728","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583598728?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:22","pubTimestamp":1763040153,"startTime":"0","endTime":"0","summary":"BRIEF-Arcutis Canada Says Health Canada Approves ZORYVE Foam 0.3% For Scalp, Body Psoriasis For Adults & Adolescents 12 & OlderNov 13  - Arcutis Biotherapeutics Inc ARQT.O:ARCUTIS CANADA: HEALTH CANADA APPROVES ZORYVE FOAM 0.3% FOR SCALP, BODY PSORIASIS FOR ADULTS & ADOLESCENTS AGES 12 & OLDER CANADA NEWSWIRE ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP0M6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583059865","title":"Refile-Arcutis Canada: Health Canada Approves Zoryve Foam 0.3% for Scalp, Body Psoriasis for Adults & Adolescents 12 & Older (Removes Extra Words)","url":"https://stock-news.laohu8.com/highlight/detail?id=2583059865","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583059865?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:05","pubTimestamp":1763039104,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nFWN3WP0M6:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583607095","title":"Arcutis Biotherapeutics Inc - Topline Results Expected in Q1 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2583607095","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583607095?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:00","pubTimestamp":1763038806,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUA21DZK7:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2583604195","title":"Arcutis Completes Enrollment in Integument-Infant Phase 2 Study Evaluating Zoryve® (Roflumilast) Cream 0.05% in Infants With Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2583604195","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583604195?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:00","pubTimestamp":1763038806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251113:nTUA21DZK7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582386100","title":"Arcutis Biotherapeutics Inc. Chief Medical Officer Patrick Burnett Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2582386100","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582386100?lang=en_us&edition=fundamental","pubTime":"2025-11-11 06:42","pubTimestamp":1762814547,"startTime":"0","endTime":"0","summary":"Patrick Burnett, an officer of Arcutis Biotherapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 10, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nNDL9kxSMV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Arcutis Biotherapeutics Inc. Chief Medical Officer Patrick Burnett Reports Sale of Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2582817880","title":"H.C. Wainwright Sticks to Their Buy Rating for Arcutis Biotherapeutics (ARQT)","url":"https://stock-news.laohu8.com/highlight/detail?id=2582817880","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582817880?lang=en_us&edition=fundamental","pubTime":"2025-11-10 09:16","pubTimestamp":1762737366,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Douglas Tsao from H.C. Wainwright maintained a Buy rating on Arcutis Biotherapeutics, with a price target of $30.00...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-arcutis-biotherapeutics-arqt-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/h-c-wainwright-sticks-to-their-buy-rating-for-arcutis-biotherapeutics-arqt-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581834612","title":"BRIEF-Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2581834612","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581834612?lang=en_us&edition=fundamental","pubTime":"2025-11-08 05:47","pubTimestamp":1762552047,"startTime":"0","endTime":"0","summary":"BRIEF-Arcutis Biotherapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)Nov 8 (Reuters) - Arcutis Biotherapeutics Inc ARQT.O:ARCUTIS BIOTHERAPEUTICS REPORTS INDUCEMENT GRANTS UNDER","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251107:nTUAFXRHV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2581086105","title":"Director Howard G. Welgus Reports Disposal of Arcutis Biotherapeutics Inc. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2581086105","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581086105?lang=en_us&edition=fundamental","pubTime":"2025-11-06 07:24","pubTimestamp":1762385089,"startTime":"0","endTime":"0","summary":"Howard G. Welgus, Director at Arcutis Biotherapeutics Inc., has reported the disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 05, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251105:nNDL2F6Ww4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Howard G. Welgus Reports Disposal of Arcutis Biotherapeutics Inc. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580740731","title":"Arcutis Reports Positive Long-Term Safety Results for ZORYVE Foam in Seborrheic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2580740731","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580740731?lang=en_us&edition=fundamental","pubTime":"2025-11-04 21:00","pubTimestamp":1762261247,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics Inc. has announced the publication of positive long-term safety and efficacy data for ZORYVE  Foam 0.3% in individuals with seborrheic dermatitis. The results, published in the American Journal of Clinical Dermatology, are from a Phase 2 long-term safety open-label extension study. The study demonstrated that once-daily ZORYVE foam 0.3% is safe, well-tolerated, and maintains durable efficacy for up to 52 weeks in adults and adolescents aged 9 years and older. The most common treatment-emergent adverse events were COVID-19 and headache, with low rates of serious adverse events and treatment discontinuations. The study results have already been published.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biot","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251104:nNDL2w4tK6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4588","BK4585","IE00BGHQF748.EUR","ARQT","LU2210149790.SGD","BK4139","LU2095319765.USD","LU0314104364.USD","NDAQ","BK4112","IE00B64PRP62.GBP","IE00BKPKM429.USD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580271499","title":"A Look at Arcutis Biotherapeutics's Valuation Following Q3 Results and ZORYVE Launch for Pediatric Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=2580271499","media":"Simply Wall St.","labels":["productRelease","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580271499?lang=en_us&edition=fundamental","pubTime":"2025-11-04 07:21","pubTimestamp":1762212076,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics (ARQT) just announced impressive third quarter results and the commercial launch of ZORYVE cream 0.05% for treating atopic dermatitis in young children in the U.S. Investors are taking notice because this milestone expands the company's reach.\nSee our latest analysis for Arcutis Biotherapeutics.\nArcutis Biotherapeutics has seen momentum surge lately, as a flurry of positive news ranging from robust Q3 results and upbeat financial guidance to product launches in...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/a-look-at-arcutis-biotherapeuticss-valuation-following-q3-re","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/a-look-at-arcutis-biotherapeuticss-valuation-following-q3-re","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2580889952","title":"Could Expanding ZORYVE to Younger Children Reshape Arcutis Biotherapeutics’ (ARQT) Long-Term Growth Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2580889952","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2580889952?lang=en_us&edition=fundamental","pubTime":"2025-11-02 15:47","pubTimestamp":1762069675,"startTime":"0","endTime":"0","summary":"In the past week, Arcutis Biotherapeutics announced the commercial launch of ZORYVE cream 0.05% for mild to moderate atopic dermatitis in children ages 2 to 5 years in the US, making it available in pharmacies and aiming for broad insurance coverage.\nThis move not only extends ZORYVE’s reach into a younger pediatric demographic but also follows strong third-quarter financial results and new clinical evidence supporting long-term benefits for patients and families.\nWe'll now examine how...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/could-expanding-zoryve-to-younger-children-reshape-arcutis-b","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/could-expanding-zoryve-to-younger-children-reshape-arcutis-b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579043471","title":"Arcutis Biotherapeutics CEO Todd Watanabe Reports Sale of Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2579043471","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579043471?lang=en_us&edition=fundamental","pubTime":"2025-10-31 07:03","pubTimestamp":1761865383,"startTime":"0","endTime":"0","summary":"Todd Watanabe, Director and Officer of Arcutis Biotherapeutics Inc., reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Arcutis Biotherapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on October 30, 2025, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nNDL2cfdnd:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118254730","title":"Stock Track | Arcutis Biotherapeutics Soars 5.49% on Zoryve Launch for Pediatric Atopic Dermatitis","url":"https://stock-news.laohu8.com/highlight/detail?id=1118254730","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118254730?lang=en_us&edition=fundamental","pubTime":"2025-10-30 22:00","pubTimestamp":1761832854,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics Inc. (ARQT) saw its stock soaring 5.49% in pre-market trading on Thursday, following the announcement of a significant product launch. The company has officially introduced...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579114522","title":"Arcutis Launches Zoryve® (Roflumilast) Cream 0.05% for the Treatment of Mild to Moderate Atopic Dermatitis in Children Ages 2 to 5","url":"https://stock-news.laohu8.com/highlight/detail?id=2579114522","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579114522?lang=en_us&edition=fundamental","pubTime":"2025-10-30 20:00","pubTimestamp":1761825606,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251030:nTUACHWXQ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579190879","title":"Arcutis Biotherapeutics (ARQT): Projected 24% Annual Revenue Growth Shapes Value Narrative Ahead of Earnings","url":"https://stock-news.laohu8.com/highlight/detail?id=2579190879","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579190879?lang=en_us&edition=fundamental","pubTime":"2025-10-30 14:34","pubTimestamp":1761806044,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics (ARQT) remains unprofitable but has managed to shrink its losses over the last five years, recording a 3.3% annual rate of improvement. The company’s revenue is projected to grow at 24% per year, notably faster than the US market average of 10.2%. With a negative net profit margin but a favorable Price-to-Sales Ratio of 9.7x, trading well below biotech peers and the broader industry, Arcutis offers a compelling risk and reward setup focused squarely on strong growth...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/arcutis-biotherapeutics-arqt-projected-24-annual-revenue-gro","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-arqt/arcutis-biotherapeutics/news/arcutis-biotherapeutics-arqt-projected-24-annual-revenue-gro","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ARQT"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579724119","title":"Morgan Stanley Raises Price Target on Arcutis Biotherapeutics to $32 From $21, Keeps Overweight Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2579724119","media":"MT Newswires Live","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579724119?lang=en_us&edition=fundamental","pubTime":"2025-10-29 19:17","pubTimestamp":1761736658,"startTime":"0","endTime":"0","summary":"Arcutis Biotherapeutics (ARQT) has an average rating of buy and mean price target of $29.13, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from m","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARQT","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":7,"pageCount":5,"totalSize":126,"code":"91000000","status":"200"}]}}